Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma

  1. Suvannasankha, A.
  2. Bahlis, N.
  3. Trudel, S.
  4. Weisel, K.
  5. Koenecke, C.
  6. Oriol, A.
  7. Voorhees, P.M.
  8. Alonso, A.A.
  9. Callander, N.S.
  10. Mateos, M.-V.
  11. Reddy, N.
  12. Hakim, S.
  13. LaMacchia, J.
  14. Patel, N.
  15. Williams, D.
  16. Jewell, R.C.
  17. Zhou, X.
  18. Gupta, I.
  19. Opalinska, J.
  20. Nooka, A.K.
Revue:
Cancer

ISSN: 1097-0142,  0008-543X

Année de publication: 2024

Type: Article

DOI: 10.1002/CNCR.35319 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus